PresbiDrops

N/A

Report date: 2026/02/04 17:20:19
NME

Base Information

Drug NamePresbiDrops
Drug Alias Namepilocarpine + diclofenac
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor agonists
TargetsMuscarinic acetylcholine receptor
Therapy Area/IndicationsPresbyopia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsYes
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrasis Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrasis Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsPresbyopia

Other Information

ATC CodeN/A
Related LinksN/A